EPTIS
BAM Logo

Myeloproliferative Neoplasms Diagnostic Testing (not accredited)

EPTIS factsheet 941730 | Last revision 2022-06-08 | URL: https://www.eptis.bam.de/pts941730 https://www.eptis.bam.de/pts941730

PT provider
PT provider UK NEQAS for Leucocyte Immunophenotyping UK NEQAS for Leucocyte Immunophenotyping
Based in United Kingdom
Language(s) English
Remarks Please see UK NEQAS LI website for further information (http://www.ukneqasli.co.uk/)
Keywords
Product groups
Testing fields Biology
Medical analysis
Technical details
Test item Tested property Testing method
Lyophilised preparations Detection of JAK2 (V617F and exon 12), CALR exon 9 and MPL exon 10 pathogenic variants Various single gene molecular biology techniques for the analysis of nucleic acids (DNA)
Aims of the PT scheme
Target group of participants Participation open to both UK and international laboratories.
Linked to specific legislation / standards ISO 17043:2010 ISO 13528:2015 ISO 15189:2012
Additional, subsidiary aims validation of testing methods
Number of participants 90
Accredited or otherwise reviewed by a 3rd party

Accredited by UKAS on the basis of ISO/IEC 17043

Operation is commissioned / requested by
Fees and frequency
Participation fee Please contact UK NEQAS LI for details
Regularly operated Yes (Yes (1 per annum (each send-out includes 1 sample)))
Year of first operation 2018
Contact details of the PT provider
Provider Contact person
UK NEQAS for Leucocyte Immunophenotyping
4th Floor, Pegasus House, 463a Glossop Road
S10 2QD Sheffield
United Kingdom

Phone: +44 (0) 114 2673600
Fax:
Web: http://www.ukneqasli.co.uk http://www.ukneqasli.co.uk
Mr Stuart Scott
Phone: +44 (0) 114 2673600
Fax:
Email: admin@ukneqasli.co.uk admin@ukneqasli.co.uk
If you find any mistakes please contact the responsible EPTIS coordinator in United Kingdom, Mr Savvas Xystouris. Mr Savvas Xystouris.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.21